HCW Biologics Inc. Cash and Restricted Cash
HCW Biologics Inc. (HCWB) had Cash and Restricted Cash of $1.95 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-31
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.95M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.10M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.44M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.11M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $1.95M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.44M 10-Q · filed 2025-08-18 |
| 2025-03-31 | $1.11M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.67M 10-K · filed 2026-03-31 |
| 2024-09-30 | $998.22K 10-Q · filed 2025-11-14 |
| 2024-06-30 | $1.16M 10-Q · filed 2025-08-18 |
| 2024-03-31 | $4.08M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $3.60M 10-K · filed 2026-03-31 |
| 2023-09-30 | $11.22M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $7.45M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $18.39M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $22.33M 10-K · filed 2025-03-28 |
| 2022-09-30 | $26.22M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $15.42M 10-Q · filed 2023-08-11 |
| 2022-03-31 | $18.12M 10-Q/A · filed 2023-08-10 |
| 2021-12-31 | $11.73M 10-K/A · filed 2024-05-15 |
| 2021-09-30 | $15.13M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $5.05M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $6.86M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $8.46M 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |